Baroque Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.27 Cr
- Paid Up Capital ₹ 1.68 Cr
- Company Age 31 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 129.60 Cr
- Satisfied Charges ₹ 7.51 Cr
- Revenue Growth -12.61%
- Profit Growth -37.60%
- Ebitda -35.19%
- Net Worth 10.62%
- Total Assets 18.20%
About Baroque Pharmaceuticals
Baroque Pharmaceuticals Pvt Ltd (BPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 November 1993 and has a history of 31 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Baroque Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.27 Cr and a paid-up capital of Rs 1.68 Cr.
The company currently has active open charges totaling ₹129.60 Cr. The company has closed loans amounting to ₹7.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pragnesh Patel, Jayantibhai Patel, Jignesh Patel, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ1993PTC020695
- Company No.
020695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Baroque Pharmaceuticals Pvt Ltd offer?
Baroque Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Diclofenac, Diclofenac Sodium Injection, Chemical Reagents & Catalysts, Calcium Carbonate Powder, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Kidney Drugs, Diabetes Medicine, Common Disease Medicines.
Who are the key members and board of directors at Baroque Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayantibhai Patel  | Managing Director | 01-Apr-1996 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pragnesh Patel | Director | 01-May-2003 | Current |
| Jignesh Patel | Whole-Time Director | 01-Apr-2008 | Current |
| Lalit Saraswat | Director | 01-May-2011 | Current |
Financial Performance of Baroque Pharmaceuticals.
Baroque Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.61% decrease. The company also saw a substantial fall in profitability, with a 37.6% decrease in profit. The company's net worth Soared by an impressive increase of 10.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baroque Pharmaceuticals?
In 2023, Baroque Pharmaceuticals had a promoter holding of 94.37% and a public holding of 5.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹129.60 Cr
₹7.51 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 129.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2016 | State Bank Of India | ₹62.80 Cr | Open |
| 18 Mar 2016 | State Bank Of India | ₹62.80 Cr | Open |
| 20 Dec 2014 | State Bank Of India | ₹4.00 Cr | Open |
| 01 Oct 2016 | Hdfc Bank Limited | ₹1.20 M | Satisfied |
| 09 Mar 2015 | State Bank Of India | ₹4.50 M | Satisfied |
How Many Employees Work at Baroque Pharmaceuticals?
Baroque Pharmaceuticals has a workforce of 225 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baroque Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baroque Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.